Tricia M. Peters

Dr. Tricia M. Peters


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
TPTricia M. Peters
Tricia M. Peters
MHMichael V. Holmes
Michael V. Holmes
JRJ. Brent Richards
J. Brent Richards
TPTom Palmer
Tom Palmer
VFVincenzo Forgetta
Vincenzo Forgetta
SISanne Peters, The George Institute
Sanne Peters, The George Institute
OBJECTIVE: Observational studies have demonstrated that type 2 diabetes is a stronger risk factor for coronary heart disease (CHD) in women compared with men. However, it is not clear whether this reflects a sex differential in the causal effect of diabetes on CHD risk or results from sex-specific residual confounding. RESEARCH DESIGN AND METHODS: Using 270 single nucleotide polymorphisms (SNPs) for type 2 diabetes identified in a type 2 diabetes genome-wide association study, we performed a sex-stratified Mendelian randomization (MR) study of type 2 diabetes and CHD using individual participant data in UK Biobank (251,420 women and 212,049 men). Weighted median, MR-Egger, MR-pleiotropy residual sum and outlier, and radial MR from summary-level analyses were used for pleiotropy assessment. RESULTS: MR analyses showed that genetic risk of type 2 diabetes increased the odds of CHD for women (odds ratio 1.13 [95% CI 1.08–1.18] per 1-log unit increase in odds of type 2 diabetes) and men (1.21 [1.17–1.26] per 1-log unit increase in odds of type 2 diabetes). Sensitivity analyses showed some evidence of directional pleiotropy; however, results were similar after correction for outlier SNPs. CONCLUSIONS: This MR analysis supports a causal effect of genetic liability to type 2 diabetes on risk of CHD that is not stronger for women than men. Assuming a lack of bias, these findings suggest that the prevention and management of type 2 diabetes for CHD risk reduction is of equal priority in both sexes.

6 August 2019 in Current Diabetes Reports
Verified
Journal Article
Closed access
TPTricia M. Peters
Tricia M. Peters
ABAnne-Sophie Brazeau
Anne-Sophie Brazeau

31 January 2024 in Diabetes Technology & Therapeutics
Verified
Journal Article
Closed access
CSCourtney A. South
Courtney A. South
MTMeryem K. Talbo
Meryem K. Talbo
ARAmélie Roy-Fleming
Amélie Roy-Fleming
TPTricia M. Peters
Tricia M. Peters
DNDaiva Nielsen
Daiva Nielsen
ABAnne-Sophie Brazeau
Anne-Sophie Brazeau
Introduction: Automated insulin delivery (AID) systems reduce burden and improve glycemic management for people with type 1 diabetes (PwT1D) by automatically adjusting insulin as a response to measured glucose levels. There is a lack of evidence on AID and nutrition variables such as dietary intake, eating behaviors, and disordered eating. Objectives: This scoping review aims to provide a summary of the literature regarding AID and nutrition variables and to identify gaps that require further investigation. Methods: Two researchers conducted a blinded search of Medline (OVID) and PubMed for studies, including AID use (compared to non-AID use) and nutrition variables. Studies from January 2000 to July 2023 were included, as were PwT1D of all ages. Results: A total of 3132 articles were screened for appropriateness. After exclusions, 7 studies were included (2017–2023): 4 qualitative, 1 crossover, 1 randomized controlled, and 1 observational. Studies included adolescents ( n = 1), adults ( n = 3) or both ( n = 2), and all ages ( n = 1). In quantitative studies, AID was associated with lower eating distress (−0.43 ± 0.12, P = 0.004) and higher quality of life (3.1, 95% confidence interval [CI]: 0.8–5.4, P = 0.01), but not grams of carbohydrates at meals (1.0; 95% CI: −0.7 to 3.0; P = 0.24) and snacks (0.004; 95% CI: −0.8 to 0.8; P = 0.99) compared to non-AID use. In qualitative studies, AID increased the frequency and portions of food intake and led to less dietary control from parents. AID users reported eating foods higher in energy density. PwT1D were less worried about achieving accurate carbohydrate counting (CC) when using AID. Conclusions: AID use appears to influence eating behaviors, dietary patterns, and CC, although evidence was limited. AID may reduce food management burden due to the perception that AID can correct for CC inaccuracy. Significance: Further research needs to determine if AID allows for simplification of CC and improves eating behaviors while maintaining glycemic stability.

12 January 2026 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Open access
AKAlexandra Katz
Alexandra Katz
ASAidan Shulkin
Aidan Shulkin
AHAsmaa Housni
Asmaa Housni
ARAmélie Roy‐Fleming
Amélie Roy‐Fleming
RRRémi Rabasa‐Lhoret
Rémi Rabasa‐Lhoret
ABAnne-Sophie Brazeau
Anne-Sophie Brazeau
Glucocorticoids (GCs) are widely utilised for the treatment of inflammatory and autoimmune conditions but often precipitate significant hyperglycaemia. People with type 1 diabetes (PWT1D) may be particularly affected due to the challenges of adjusting insulin dosing, for which recommendations remain unclear. Our aim is to synthesise the evidence on the glycaemic effects of GCs in PWT1D across various formulations, doses and administration routes, and to outline management strategies. In August 2025, a systematic search of MEDLINE, Embase and CENTRAL was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta‐Analysis guidelines. Eligible studies included adult PWT1D exposed to GCs and reported glycaemic outcomes and/or management strategies. Twenty‐two studies were included, comprising 368 PWT1D. GC exposure was consistently associated with marked hyperglycaemia and increased insulin requirements. Oral and intravenous GC regimens required substantial insulin dose escalation, in many cases up to 70% from baseline. During pregnancy, antenatal corticosteroids were best managed with structured subcutaneous or intravenous insulin protocols. Local injectable GCs caused delayed but prolonged excursions and required careful blood glucose (BG) monitoring. Emerging data suggest that automated‐insulin delivery (AID) systems attenuate BG elevation but still require user intervention. Thus, GC therapy in PWT1D destabilises glycaemic management, though impact and timing vary by formulation, dose, administration route, patient‐specific factors and clinical context. Proactive, individualised insulin adjustments aligned with GC pharmacokinetics and frequent BG monitoring or continuous glucose monitor use represent the most practical current strategy. Further research is required to develop evidence‐based guidelines and to clarify the role of AID.

12 February 2025 in Canadian Journal of Diabetes
Verified
Journal Article
Open access
TPTricia M. Peters
Tricia M. Peters
ABAnne-Sophie Brazeau
Anne-Sophie Brazeau
Lia BallyLia Bally
Lia Bally
AGAlexa Govette
Alexa Govette
EHElsa HEYMAN
Elsa HEYMAN
JYJane Yardley
Jane Yardley

22 March 2025 in Journal of Adolescent Health
Verified
Journal Article
Open access
TPTricia M. Peters
Tricia M. Peters
TCTuck Seng Cheng
Tuck Seng Cheng
SBSoren Brage
Soren Brage
KOKen K. Ong
Ken K. Ong
Physical activity (PA) is recommended for the management of women with polycystic ovary syndrome (PCOS). However, it is not known whether PA modulates the risk of components of PCOS diagnostic criteria during adolescence. We included participants from the Avon Longitudinal Study of Parents and Children prospective cohort with objective measurement of PA and sedentary behavior using accelerometry between ages 11 and 15 years, biochemical and clinical measures of hyperandrogenism (serum total testosterone level at 15 years and self-reported hirsutism at 19 years), and self-reported menstrual regularity at 17 years. Two-stage regression models evaluated the association of repeated measures of PA and sedentary behavior with components of PCOS diagnostic criteria. Among 1,526 singleton girls with accelerometer data and testosterone samples, time spent in light PA was inversely associated with total testosterone (ß = -0.070, 95% CI -0.114, -0.025; nmol/L, per 60 minutes) and continuous hirsutism score (ß = -0.756, 95% CI -1.41, -0.103; per 60 minutes). Conversely, time spent sedentary was associated with higher total testosterone level (ß = 0.052, 95% CI 0.013, 0.090; per 60 minutes) and hirsutism score (ß = 0.668, 95% CI 0.103, 1.23; per 60 minutes). Associations were independent of adiposity, but results for hirsutism were attenuated following adjustment for age at menarche and after stratification by hormonal contraceptive use. No associations were observed with menstrual irregularity, for other PA intensity components, or among users of hormonal contraceptives. More time spent in light intensity physical activity and less time spent sedentary during early adolescence is associated with lower testosterone concentrations and lower hirsutism scores in late adolescence.